Child Health Evaluation and Research Unit

Slides:



Advertisements
Similar presentations
Hospital Issues and Smallpox Vaccine Lisa G. Kaplowitz, M.D., M.S.H.A. Deputy Commissioner Emergency Preparedness and Response Virginia Department of Health.
Advertisements

Back to the Future? Pre-Event Smallpox Vaccination John R. Lumpkin, MD, MPH, FACEP Illinois Department of Public Health.
1 VAERS Reporting During a Large Scale Vaccination Clinic in Chicago Lessons Learned Chicago Department of Public Health Immunization Program Lorraine.
The Hidden Health Care Workforce: A Report of the California 21st Century Workforce Project Susan Chapman MPH, RN UCSF Center for the Health Professions.
Introduction to Developing a Vaccination Strategy for Smallpox Preparedness Department of Health and Human Services Centers for Disease Control and Prevention.
Benefits for using a standardised risk management framework to risk assess Infection Prevention and Control Sue Greig Senior Project Officer National.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
National Smallpox Vaccination Update Joseph M. Henderson Centers for Disease Control and Prevention.
Smallpox Vaccination: Federal Activities Walter A. Orenstein, M.D. National Immunization Program Centers for Disease Control and Prevention.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
1 Influenza Vaccination of Health-care Personnel: An Initiative to Improve a Serious Public Health Problem Anand Parekh, MD, MPH Office of Public Health.
University of Michigan Health System Tracking and Evaluation of H1N1 Vaccine Implementation by Immunization Grantees Sarah Clark Child Health Evaluation.
1 California Public Health Preparedness: Lessons from Seven Jurisdictions R. Burciaga Valdez, PhD June 8, 2004.
Smallpox Vaccine Program: Communications with the Public and Stakeholders Department of Health and Human Services Centers for Disease Control and Prevention.
University of Michigan Health System Tracking State-Level Implementation of H1N1 Vaccination Grantees Sarah Clark Child Health Evaluation and Research.
BIOTERRORISM AND LEGAL ISSUES: THE TEXAS EXPERIENCE NGA REGIONAL BIOTERRORISM WORKSHOP March 15, 2004 Susan K. Steeg General Counsel Texas Department of.
Protecting our Protectors Forum on Catastrophe Preparedness: Partnering to Protect Workplaces Max Kiefer Associate Director, Emergency Preparedness and.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
1 Copyright © 2011 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Health Care Regulatory and Certifying Agencies.
Preparing for Smallpox Edward P. Richards, JD. MPH Director, Program in Law, Science, and Public Health Harvey A. Peltier Professor of Law Louisiana State.
University of Michigan Health System Children with Special Health Care Needs: Looking Back; Looking Forward Gary L. Freed, MD, MPH Director, Division of.
Public Health Options for Implementing Vaccine Recommendations: A Framework for State Decision Making Donald Williamson, M.D. National Vaccine Advisory.
Smallpox Vaccination Campaign: A Federal Perspective William Raub, Ph.D. Deputy Assistant Secretary Office of Public Health Emergency Preparedness Department.
Provider Participation in State Immunization Registries Sarah Clark Anne Cowan University of Michigan Child Health Evaluation and Research Unit Division.
Karen Cheung, MPH, Pamela Luna, DrPH, MST, Sarah Merkle, MPH American Evaluation Association Annual Meeting November 11, 2009 The findings and conclusions.
TOTAL QUALITY MANAGEMENT
Done by: Sandra Goodall Liza McGill Elecia Trowers Vivarian Malcolm.
State-Specific Prevalence of Asthma Among Adults, by Industry and Occupation — Behavioral Risk Factor Surveillance System, 21 States, 2013 Katelynn E.
CLINICAL TRIALS.
Hepatitis C Virus Program in Chicago
Notification of Observation Status
Randall (Randy) Snyder, PT, MBA Division Director January 27, 2016
Turning Best Practice into Common Practice Connecting Michigan for Health Lansing, MI June 8, 2017 Ewa Matuszewski.
CMS Policy & Procedures
State Experiences during Different Stages of the H1N1 Pandemic
The Problem of Multiple Hats: Providing efficient and safe team-based care with providers who are not always in the clinic. Frank Babb, MD David RM Trotter,
National Immunization Conference April 19, 2010
Ebola Virus Table Top Exercise
Myriam Hernandez Jennings
Keys to Practice-Based Immunization Recall
Disaster Response – A Collaboration
Increase compliance of Personal Protective Equipment
Laura E. Pechta, PhD, Centers for Disease Control and Prevention
VFC Site Visit Questionnaire and AFIX as Tools for Quality Assessment
Fatigue in the workplace: A system approach to mitigate fatigue
Results from the Field:
Management Structures
Everyone counts: working together to tackle Delayed Transfers of Care
Mark Lobato, MD Division of TB Elimination
Research for all Sharing good practice in research management
Colorado’s Health Emergency Line for the Public (COHELP): Addressing Surge Capacity through Information Exchange Gregory M. Bogdan, Ph.D. Research Director.
EmEx-Compare Emergency Department Benchmarking
Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C
Animal Welfare EU Strategy
Department of Health Hospice Update 2018
Collaborative Efforts in California to Prepare for the HPV Vaccine
Optum’s Role in Mycare Ohio
Emergency Preparedness Requirements
Child Health Evaluation and Research Unit
Smallpox Vaccinee Evaluation and Follow-Up
Ebola Facts October 15, 2014.
Maryland HCW Influenza Vaccination Survey Highlights
By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.
University of Washington
Akiko C. Kimura, MD Jeffrey Higa, MPH Christine Nguyen, MPH
National Immunization Conference March 7, 2006
R. Clinton Crews, MPH, Amy Paulson & Frances D. Butterfoss, Ph.D.
Tracking State-Level Implementation of H1N1 Vaccination Grantees
Presentation transcript:

Child Health Evaluation and Research Unit Division of General Pediatrics, University of Michigan Factors Related to the Formation of Smallpox Response Teams in US Hospitals                                                                                                                UM Research Team: Alex R. Kemper, MD, MS; Anne E. Cowan, MPH; Matthew M. Davis, MD, MAPP; Emily J. Kennedy, MPH; Sarah J. Clark, MPH; and Gary L. Freed, MD, MPH CDC Collaborator: Pamela L.Y.H. Ching, MS, SD, RD, LD National Immunization Conference May 13, 2004

Background October 2002: ACIP/HICPAC recommended that hospitals vaccinate teams of healthcare workers to prepare for a potential smallpox outbreak January 2003: Smallpox Pre-Event Vaccination Program (SPVP) implemented at state and local levels with CDC assistance Hospital participation lower than expected

Objectives Understand factors influencing hospitals’ decisions to participate in the SPVP Identify factors that would lead non-participants to change their decision Describe policies developed by participating hospitals to implement vaccination program

Methods: Hospital Selection Smallpox preparedness coordinators from 24 states with estimated hospital participation of 25-75% were contacted by CDC 9 states provided hospital contact information: CA, KY, ME, MI, MS, MN, UT, VA, and WY Acute care hospitals chosen to represent variation in size, county, affiliation, and decision to participate in SPVP 148 hospitals in final sample Ranged from 5 in MS to 21 in UT

Methods: Interview Process Semi-structured telephone interviews were conducted with hospital decision-makers between June-November 2003 Interview protocol (~20 minutes): Individuals involved in decision Hospital’s ultimate decision Whether specific factors considered Key factor(s) in decision SPVP participants: program implementation SPVP non-participants: factors that would change decision

Specific Factors Addressed in Interview Perceived risk of smallpox outbreak Risks of vaccination Safety for vaccinees Exposure of patients/close contacts of employees Policies for vaccinated employees Costs to hospital Compensation for adverse events Liability Other costs Stakeholder influences Employees General public Other outside parties

Results Decision-makers at 123 of 148 hospitals (83%) were interviewed Response rates ranged from 60-94% across states 88 of 123 hospitals (72%) decided to participate in SPVP No staff were vaccinated at 22 of these 88 hospitals

Factors Considered in Decision Chose to Participate in SPVP (n=88) Chose Not to Participate in SPVP (n=35) Risk of a Smallpox Outbreak 88% (77) 91% (32) Risks of Vaccination 90% (79) 100% (35) Potential for adverse events in vaccinees 82% (72) 97% (34) Exposure of close contacts of vaccinees 63% (55) 80% (28) Need for policies for vaccinated employees 57% (50) 60% (21) Costs to the Hospital 91% (80) 94% (33) Compensation for adverse events 78% (69) 89% (31) Liability 77% (68) 83% (29) Other financial or opportunity costs 28% (25) 26% (10) Stakeholder Influences 72% (63) 74% (26) Employees 38% (33) 37% (13) General public 34% (30) 26% (9) Other outside parties 44% (39) 49% (17)

Factors Considered in Decision (continued) Risk of Smallpox Outbreak Hospitals made own assessment of risk of a smallpox outbreak Many also assessed their perceived risk of exposure e.g., proximity to urban areas, likelihood of receiving case as transfer patient Almost all felt the risk of outbreak was low “The risk of an outbreak didn’t seem likely, but if it were to happen, it would be devastating and we felt we needed to be prepared ahead of time.”

Factors Considered in Decision (continued) Risks of Vaccination Participating hospitals found ways to address safety concerns e.g., employee education, screening protocols Those that decided not to participate had unresolved concerns about vaccine safety or determined that risks too great Many hospitals struggled over need to develop employee policies to protect contacts of vaccinees

Factors Considered in Decision (continued) Costs to Hospital Regardless of decision, liability and workers’ compensation major concerns federal legislation did not necessarily alleviate concerns Workers’ compensation addressed in varying ways A few smaller hospitals concerned with cost of lost work time (e.g., nursing shortages)

Factors Considered in Decision (continued) Stakeholder Influences Employees not a significant influence though unions very influential in some cases Public opinion not a major consideration balance between positive view of being prepared with stigma of “smallpox hospital” label Main outside stakeholders: local and state health departments, federal government, and other hospitals within community or corporate network

Factors Considered in Decision (continued) Stakeholder Influences (continued) Influence of state and local public health officials overwhelmingly positive “Local public health officials worked along side us and we developed a better relationship regarding the entire disaster planning program” In a few cases, influence of public health officials was negative “The main reason we ended up not participating was due to the lack of preparedness and technical support from the local health department.”

Key Factors

Key Factors for Participation Hospitals that Chose to Participate in the SPVP (n=88) Responsibility to Be Prepared 75% (66) Option for Employees to be Vaccinated 12% (11) Risk of Outbreak 7% (6) Other 6% (5)

Key Factors for Non-Participation Hospitals that Chose Not to Participate in SPVP (n=35) Risk of Vaccination Greater than Risk of Outbreak 57% (20) Logistical / Cost Issues 23% (8) Unknowns Surrounding SPVP 9% (3) Other 11% (4)

Factors That Would Change Non-Participants’ Decision Outbreak of smallpox somewhere in world most commonly cited Other factors included: more adequate compensation comprehensive information on safety of vaccine more/better information risk of outbreak

Program Participants: Recruitment Strategies Healthcare worker participation voluntary in all cases About 50% of hospitals offered vaccination to all employees Others offered vaccination only to certain personnel, with wide variability across hospitals: “We concentrated on ED staff due to their high skill level. We also tried to get volunteers from Infectious Disease, Dermatology, and Psychiatry.” “Vaccine was offered only to patient care providers (RNs, MDs, ED staff), security officers, and infection control.” “Vaccine was offered to everyone except personnel in obstetrics and oncology.”

Program Participants: Recruitment Strategies (continued) Given occupational mix of vaccinees, few hospitals developed specific smallpox response teams At the vast majority of hospitals, only nurses or physicians were vaccinated Ancillary staff (e.g., housekeeping, security), laboratory personnel, respiratory therapists, and radiology technicians were rarely vaccinated

Program Participants: Site Care Almost all hospitals developed a policy for care of the vaccination site Most designated staff to perform site checks, usually an employee health or infection control nurse Several hospitals allowed vaccinated staff to check their sites themselves Most adhered to recommendation that site checks be conducted daily

Program Participants: Policies for Vaccinated Staff Some hospitals went above and beyond guidelines with respect to employee leave / reassignment policies One hospital furloughed vaccinees (3-day, paid) Several hospitals reassigned employees, though specific policies varied Some hospitals offered paid leave in the event of an adverse reaction to vaccination

Discussion Hospitals considered many complex issues in (1) deciding whether to participate in SPVP and (2) implementing vaccination program available information not always complete/consistent variation across hospitals even within same community State/local public health played key role in addressing–or failing to address–uncertainty

Discussion (continued) Future smallpox preparedness efforts can benefit from: consistent messages conveyed across all levels of public health a more collaborative approach between local public health officials and individual hospitals buy-in from national level stakeholders (e.g., American Hospital Association)